The conclusions reveal that when morphine tolerance happens in CRC, inhibiting UGT2B7 expression would be beneficial to its tolerance reverse by significantly declining the productions of M6G comparing to M3G. This evidence concerns the gene UGT2B7 and colorectal carcinoma.